Prognostic significance of submaximal negative dobutamine stress echocardiography: a 3-year follow-up study.

BACKGROUND To estimate the prognostic value of submaximal negative dobutamine stress echocardiography (NDSE) on major cardiac events. METHODS AND RESULTS Patients with NDSE were analyzed in 2 cohorts based on predicted maximal heart rate (PMHR) (< 85% or > or = 85% PMHR) and were assessed for major adverse cardiac events over 3 years. Of 756 patients with NDSE, 415 achieved > or = 85% PMHR. Both groups had comparable ejection fractions (EF) > 50% (80.6% vs. 81.9%, p = 0.66). The NsubDSE group had higher rates of atrioventricular nodal blocker use (58.7% vs. 39.9%, p < 0.0001), and diabetes (38.7% vs. 27.6%, p = 0.001). Kaplan-Meier survival analysis showed no differences in freedom from cardiac death (98% vs. 98%, p = 0.88), nonfatal myocardial infarction (94% vs. 94%, p = 0.85), or combined major cardiac events (81% vs. 78%, p = 0.24). Diabetes and preserved ejection fraction were predictive of cardiac events in a multi-variate analysis (p = 0.005). CONCLUSIONS In our study, NsubDSE carried a favorable prognosis. Diabetics were more likely to have an NsubDSE and suffer from a cardiac event despite a preserved ejection fraction. Hence further evaluation for coronary artery disease in this high risk cohort should be pursued.

[1]  E. Picano,et al.  Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. , 2007, Journal of the American College of Cardiology.

[2]  J. Tardif,et al.  Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. , 2007, Journal of the American College of Cardiology.

[3]  Peter Lindgren,et al.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary , 2007 .

[4]  E. Picano,et al.  Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. , 2006, Journal of the American College of Cardiology.

[5]  James R. Anderson,et al.  Prognostic Value of Dobutamine Stress Myocardial Contrast Perfusion Echocardiography , 2005, Circulation.

[6]  K. Bailey,et al.  Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease. , 2004, The American journal of cardiology.

[7]  E. Schick,et al.  Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: importance of resting wall motion abnormalities. , 2004, Journal of the American College of Cardiology.

[8]  Jeroen J. Bax,et al.  Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. , 2004, The American journal of medicine.

[9]  Jeroen J. Bax,et al.  Prognostic value of dobutamine stress echocardiography in patients with normal left ventricular systolic function. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  Jeroen J. Bax,et al.  Long-term prognosis after normal dobutamine stress echocardiography. , 2003, The American journal of cardiology.

[11]  M. Lauer,et al.  Prediction of mortality using dobutamine echocardiography. , 2001, Journal of the American College of Cardiology.

[12]  Jeroen J. Bax,et al.  Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. , 1999, Circulation.

[13]  M. Lauer,et al.  Cardiac outcomes in coronary patients with submaximum dobutamine stress echocardiography. , 1997, The American journal of cardiology.

[14]  I. Kronzon,et al.  Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. , 1997, Journal of the American College of Cardiology.

[15]  D. Waters,et al.  Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography. , 1996, Journal of the American College of Cardiology.

[16]  P M Okin,et al.  Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. , 1996, Circulation.

[17]  N. Dawson,et al.  Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease. , 1995, The American journal of cardiology.

[18]  S. Iliceto,et al.  Clinical use of stress echocardiography: factors affecting diagnostic accuracy. , 1994, European heart journal.

[19]  R. Bonow.  Prognostic assessment in coronary artery disease: Role of radionuclide angiography , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[20]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[21]  Stephen E. Brown,et al.  Echocardiographic Detection of Coronary Artery Disease During Dobutamine Infusion , 1991, Circulation.

[22]  N. Hertzer,et al.  Coronary Artery Disease in Peripheral Vascular Patients: A Classification of 1000 Coronary Angiograms and Results of Surgical Management , 1984, Annals of surgery.